Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/1998
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1182741A 3 -amidochromanylsulfonyl (thio) ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
05/27/1998CN1182737A New 2-(1H) -quinolinone compounds, process for preparing them and pharmaceutical compositions containing them
05/27/1998CN1182734A Imidaxolyl-substituted cyclohexane derivant
05/27/1998CN1182603A Brain reinforcing ointment
05/27/1998CN1182592A Stable prostaglandin E1-containing injectable composition
05/27/1998CN1182589A Medical use of 5 -hydroxymethyl -2 -furol
05/27/1998CN1038511C Imidazopyridine and preparation process and its pharmaceutic usage
05/27/1998CN1038506C Preparation process of acylaminoindole derivatives
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/26/1998US5756832 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
05/26/1998US5756818 Hydrogenation; protecting; deprotecting; clathrates
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756669 Mutants
05/26/1998US5756547 Method for the treatment of preserving organs or tissue for transplantation
05/26/1998US5756544 Carboxyalkylethers, formulations, and treatment of vascular diseases
05/26/1998US5756535 Antiarrhythmia agents; antiischemic agents; cell antiproliferative agents
05/26/1998US5756504 Tocolytic oxytocin receptor antagonists
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756495 Nervous system disorders; alzheimer's disease
05/26/1998US5756494 Protein kinase inhibitors for treatment of neurological disorders
05/26/1998US5756467 Useful in prevention and therapy of obesity and cardiovascular diseases in humans and animals; administering in food and feeds
05/26/1998US5756463 Use of insulin and IGF-1
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/26/1998US5755237 Intravenous injection
05/26/1998CA2057444C Substituted pyridyl-dihydroxy-heptenoic acid and its salts
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021193A1 Antithrombotic organic nitrates
05/22/1998WO1998021190A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998020897A1 Modulation of map kinase phosphatase 1 (mkp-1)
05/22/1998WO1998020891A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020736A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2271728A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2270634A1 Methods and compositions for stimulating neurite growth
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842941A1 Novel phosphonates, process for their preparation and pharmaceutical compositions
05/20/1998EP0842927A1 3-Amido-chromanylsulfonyl(thio)ureas, process for their preparation, their use and medicaments containing them
05/20/1998EP0842925A1 Substituted thiazolidinedione derivatives
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842661A2 Atherosclerosis treatment
05/20/1998EP0842659A1 Use of estrogen agonists/antagonists for the manufacture of a medicament for the treatment of atherosclerosis
05/20/1998EP0842273A2 Receptor ligand vegf-c
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842178A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
05/20/1998EP0842174A1 Heterocyclic compounds for treating myocardial ischaemia
05/20/1998EP0842169A1 Benzothiophene compounds
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0842161A1 4,5-diaryl oxazole derivatives
05/20/1998EP0842156A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841926A1 Endothelin receptor antagonists
05/20/1998EP0841925A1 Endothelin receptor antagonists
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841918A1 Thrombin inhibitors
05/20/1998EP0841916A1 Endothelin receptor antagonists
05/20/1998EP0841913A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
05/20/1998EP0841910A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998EP0741708B1 Cyanoguanidines as k-channel blockers
05/20/1998EP0707583B1 Process for the preparation of thiopyrans
05/20/1998EP0674636B1 Quinuclidine derivatives as squalene synthase inhibitors
05/20/1998CN1182415A Terminal carboxy or tetrazole groups containing dialkyl ethers
05/20/1998CN1182358A Triacetin as transdermal penetration enhancer
05/20/1998CN1181946A Formula of bezoar capsule and preparation process thereof
05/19/1998US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
05/19/1998US5753703 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
05/19/1998US5753688 Antiinflammatory
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753680 Heterocyclyl-benzoylguanidines
05/19/1998US5753661 Fused benzo compounds containing a nitrogen heterocycle for the treatment of central nervous system disorders
05/19/1998US5753657 Imidazo 1,2-A! pyrazine-4-one, preparation thereof and drugs containing same
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753646 Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998CA2096611C 4-benzylpiperidine derivatives and process for their production
05/19/1998CA2093666C Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
05/15/1998CA2221090A1 Method of treating atherosclerosis
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020128A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998WO1998020126A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/14/1998WO1998020027A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 1595